PHARMAC's updated guidelines for cost-effectiveness analyses, with new discount rate

被引：0
|
作者：
Grocott, Rachel [1 ]
Metcalfe, Scott [2 ]
机构：
[1] PHARMAC, Wellington, New Zealand
[2] PHARMAC, Populat Med, Wellington, New Zealand
来源：
NEW ZEALAND MEDICAL JOURNAL | 2007年 / 120卷 / 1258期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：79 / 83
页数：5
相关论文
共 50 条
  • [1] PHARMAC's updated guidelines for cost-utility analyses, with new QALYs per $1M metric
    Grocott, Rachel
    Metcalfe, Scott
    NEW ZEALAND MEDICAL JOURNAL, 2012, 125 (1358) : 89 - 90
  • [2] PHARMAC has no cost-effectiveness threshold
    Metcalfe, Scott
    Rodgers, Alexander
    Werner, Rachel
    Schousboe, Carsten
    NEW ZEALAND MEDICAL JOURNAL, 2012, 125 (1350) : 99 - 101
  • [3] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Nannan Li
    Dennis Cornelissen
    Stuart Silverman
    Daniel Pinto
    Lei Si
    Ingrid Kremer
    Sandrine Bours
    Robin de Bot
    Annelies Boonen
    Silvia Evers
    Joop van den Bergh
    Jean-Yves Reginster
    Mickaël Hiligsmann
    PharmacoEconomics, 2021, 39 : 181 - 209
  • [4] AN UPDATED SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSES OF DRUGS FOR OSTEOPOROSIS
    Li, N.
    Cornelissen, D.
    Silverman, S.
    Pinto, D.
    Si, L.
    Kremer, I.
    Bours, S.
    Boonen, A.
    Evers, S.
    van den Bergh, J.
    Reginster, J. -Y.
    Hiligsmann, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S491 - S491
  • [5] An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
    Li, Nannan
    Cornelissen, Dennis
    Silverman, Stuart
    Pinto, Daniel
    Si, Lei
    Kremer, Ingrid
    Bours, Sandrine
    de Bot, Robin
    Boonen, Annelies
    Evers, Silvia
    van den Bergh, Joop
    Reginster, Jean-Yves
    Hiligsmann, Mickael
    PHARMACOECONOMICS, 2021, 39 (02) : 181 - 209
  • [6] COST-EFFECTIVENESS ANALYSES
    STEINBERG, EP
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02): : 123 - 123
  • [7] The "e" In Cost-Effectiveness Analyses: Efficacy Or Effectiveness Of Asthma Medications Used In Cost-Effectiveness Analyses?
    Dilokthornsakul, P.
    Chaiyakunapruk, N.
    Campbell, J. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [8] Updated Recommendations for Cost-effectiveness Studies
    Jan, Stephen
    Wiseman, Virginia
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (01): : 89 - 90
  • [9] Cost-effectiveness analyses of training: a manager’s guide
    Gabrielle O’Malley
    Elliot Marseille
    Marcia R Weaver
    Human Resources for Health, 11
  • [10] OPTIMAL COST-EFFECTIVENESS ANALYSES
    NIGHTINGALE, SD
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1992, 7 (03) : 369 - 370
12345